Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 25, 2026

How The Great-West Lifeco (TSX:GWO) Story Is Shifting As Capital Strength Meets Sector Pressures

View original at finance.yahoo.com
How The Great-West Lifeco (TSX:GWO) Story Is Shifting As Capital Strength Meets Sector Pressures Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • CIBC set price target of CA$73 for Great-West Lifeco with Outperform rating, signaling confidence in the company's ability to execute on its plan

    60% confidence
  • BMO Capital trimmed price target to CA$66 and maintains Market Perform rating, highlighting a more cautious stance

    60% confidence
  • RBC Capital moved price target higher to CA$64 with Sector Perform rating, suggesting shares are reasonably placed within the life insurance peer group

    60% confidence
  • Barclays flags headwinds such as spread compression and technology spending for life insurers, which can pressure profitability

    60% confidence
  • Scotiabank set price target of CA$71 for Great-West Lifeco with Outperform rating, signaling confidence in the company's ability to execute on its plan

    60% confidence
  • Barclays moved price target to CA$70 with Equal Weight rating, pointing to capital strength, cash flow and industry consolidation as supports for life insurers heading into 2026

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com